Thirdly, we limited our analysis to G-CSF expression by the carcinoma cells, and these results do not take into account the expression of G-CSF on immune cells, such as macrophages, endothelial cells, or other stromal cells that are part of the tumour immune microenvironment. The gene discussed is CSF3; the disease is neoplasm.